Empagliflozin Improves Mitochondrial Biogenesis and Attenuates Proliferation of Microvascular Endothelial Cells in Pulmonary Arterial Hypertension

K. Yoshida; X. Pan; H. J. Bogaard

Empagliflozin Improves Mitochondrial Biogenesis and Attenuates Proliferation of Microvascular Endothelial Cells in Pulmonary Arterial Hypertension

K. Yoshida, X. Pan, H. J. Bogaard

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Journal	American journal of respiratory and critical care medicine
Volume	205
Publication status	Published - 1 May 2022

Cite this

@article{5ec861c497464ae2b9c2a64b9314965d,

title = "Empagliflozin Improves Mitochondrial Biogenesis and Attenuates Proliferation of Microvascular Endothelial Cells in Pulmonary Arterial Hypertension",

author = "K. Yoshida and X. Pan and Bogaard, {H. J.}",

year = "2022",

month = may,

day = "1",

language = "English",

volume = "205",

journal = "American journal of respiratory and critical care medicine",

issn = "1073-449X",

publisher = "American Thoracic Society",

}

TY - JOUR

T1 - Empagliflozin Improves Mitochondrial Biogenesis and Attenuates Proliferation of Microvascular Endothelial Cells in Pulmonary Arterial Hypertension

AU - Yoshida, K.

AU - Pan, X.

AU - Bogaard, H. J.

PY - 2022/5/1

Y1 - 2022/5/1

M3 - Meeting Abstract

SN - 1073-449X

VL - 205

JO - American journal of respiratory and critical care medicine

JF - American journal of respiratory and critical care medicine

ER -